Craft

Shattuck Labs

Stock Price

$1.4

2024-10-28

Market Capitalization

$64.7 M

2024-10-28

Revenue

$1.7 M

FY, 2023

Shattuck Labs Summary

Company Summary

Overview
Shattuck Labs is a biotechnology company. Its platform Agonist Redirected Checkpoint is used to build therapeutic medicines for oncology and inflammatory diseases. The therapy is based on consolidating checkpoint blockade and TNF (tumor necrosis factor) receptor agonists into single therapeutics.
Type
Public
Status
Active
Founded
2016
HQ
Durham, NC, US | view all locations
Website
https://www.shattucklabs.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Taylor H. Schreiber

    Taylor H. Schreiber, Chief Executive Officer, Co-Founder, Director

  • Lini Pandite

    Lini Pandite, Chief Medical Officer

  • Casi Deyoung

    Casi Deyoung, Chief Business Officer

  • Andrew R. Neill

    Andrew R. Neill, Chief Financial Officer

Operating MetricsView all

ARC Compounds Produced to Date

300

Oct, 2020

LocationsView all

2 locations detected

  • Durham, NC HQ

    United States

    21 Parmer Way #200

  • Austin, TX

    United States

    1018 W 11th St

Shattuck Labs Financials

Summary Financials

Revenue (Q3, 2024)
$3.0M
Net income (Q3, 2024)
($16.7M)
Cash (Q3, 2024)
$43.8M
EBIT (Q3, 2024)
($17.9M)
Enterprise value
$24.5M

Footer menu